Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has issued duplicate share certificates in lieu of the original share certificates reported lost/misplaced, details of which are enclosed. Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Change in Directorate
The Board of Directors of the Company at its Meeting held today approved the appointment of Mr. Cherian Mathew (DIN - 08522813) as Additional Director to hold the office up to the next Annual General Meeting of the Company. The Board also approved appointment of Mr. Cherian Mathew as Whole Time Director for a period of 5 years with effect from 29th July 2019 subject to approval of the members of the Company. The Board appointed Mr. Cherian Mathew as Key Managerial Personnel of the Company. Mr. Cherian Mathew is not related to any Director of the Company. He is not debarred from holding the office of Director by virtue of any SEBI order or any other Authority. A brief profile of Mr. Cherian Mathew is enclosed. Sanofi India Ltd - 500674 - Unaudited Financial Results For The Quarter And Half Year Ended 30Th June 2019
We refer to our letter dated 15th July 2019 informing you of our Board Meeting that was scheduled today. The Meeting of Board of Directors commenced at 2.30 p.m. and concluded at 04.30 p.m. The Board approved unaudited financial results for the quarter and half year ended 30th June 2019. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose a copy of the unaudited financial results of the quarter and half year ended 30th June 2019 approved at this Meeting including the Statement of Assets and Liabilities as on that date and the Statement of Cash Flow (as part of notes) for the half year ended 30th June 2019 along with a copy of the Limited Review Report duly signed by the Auditors of the Company. Sanofi ends partnership with Lexicon to develop add-on pill for diabetes
Shares of Lexicon fell nearly 40% in extended trading Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has issued duplicate share certificates in lieu of the original share certificates reported lost/misplaced, details of which are enclosed. Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has issued duplicate share certificates in lieu of the original share certificates reported lost/misplaced, details of which are enclosed. Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed copies of the Notice of the Board Meeting of the Company published today, in newspapers, Business Standard and Sakal. Sanofi India Ltd - 500674 - Shareholding for the Period Ended June 30, 2019
Sanofi India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here Sanofi India Ltd - 500674 - Board Meeting Intimation for Meeting Of Board Of Directors To Be Held On 29Th July 2019
Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the meeting of the Board of Directors of the Company will be held on Monday, 29th July 2019; inter alia to consider the unaudited financial results for the quarter and half year ended 30th June 2019 (Q2). Sanofi India Ltd - 500674 - Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0330 Name of the Signatory :- Girish TekchandaniDesignation :- Company Secretary and Compliance Officer